Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,555.22
(
0.79%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Robert C Jonson

Send PM Follow Ignore
Followers 29
Posts 2152
Boards Moderated 0
Alias Born 10/28/2007

Robert C Jonson

Re: geocappy1 post# 92290

Friday, 09/14/2012 11:07:00 AM

Friday, September 14, 2012 11:07:00 AM

Post# of 347009
or the 1st line lung cancer trial MOS

Don't forget that the 1st line NSCLC control group MOS hasn't evented, either, so we could get good 1st line MOS for our treatment arms that will be criticized because they're not overwhelmingly better than the control group.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote